About Avadel Pharmaceuticals plc

Who We Are: Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, currently approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night. Our current lead drug candidate, LUMRYZTM (sodium oxybate) extended release for oral suspension (formerly known as FT218), applies our proprietary drug delivery technology to allow for a single bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night’s sleep. An extended-release medication sounds like a simple innovation, but it is what has been lacking for 20 years, and we believe this will be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com.

What We Do: LUMRYZ has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of narcolepsy. The designation was granted on the plausible hypothesis that LUMRYZ may be clinically superior to a formulation of sodium oxybate already approved by the FDA for the same indication.

The FDA granted a tentative approval to LUMRYZ on July 18, 2022. Tentative approval indicates that LUMRYZ has met all required quality, safety, and efficacy standards necessary for approval in the U.S. FDA’s final approval decision for LUMRYZ is pending expiration or other disposition of a patent listed in FDA’s Orange Book that expires on June 17, 2023. Avadel’s market research suggests that LUMRYZ has the potential to command a meaningful share of the multi-billion-dollar narcolepsy treatment market.

We are currently taking steps to accelerate the final approval of LUMRYZ earlier than the expiry of the patent in June 2023, however, in either case, we are gearing up for our full launch now. We can’t wait to bring an innovative new treatment option to the narcolepsy community.

How We Work: At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage – our “secret sauce.” The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility, being courageous, taking insights to impact, and togetherness. In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other.

We are seeking team members who have a passion for making a meaningful impact in the lives of patients. We need individuals who will dive in, roll up their sleeves, and join us in our mission to launch LUMRYZ for the narcolepsy community and be part of building and shaping an exciting future together.

Position Summary:

Avadel is seeking exceptional individuals to be responsible for the development and direct oversight of our Field Reimbursement strategy within their assigned region. This candidate would be considered an expert in this field having worked as part of Access teams, developing pull through strategies, and working collaboratively with internal stakeholders. In this role, the successful candidates will assist in creating all educational materials for use in field reimbursement working directly with our Director, Field Reimbursement, Marketing and Medical teams. This individual will also work internally in collaboration with National Account Directors, Patient Services and Channel Director to align the right strategy for LUMRYZ. This role will work directly with Patient Service and Channel directors to ensure pull thru strategies are effective in resolving any barrier to getting patient on product.

Working as one team the Field Reimbursement Managers (FRM) will work collaboratively with there respective Territory Business Managers to align on relationship development with top HCP offices to ensure they understand the RYZUP enrollment process along with titration process once a script has been written. The FRM will be responsible for all pull thru of patient cases working directly with the office along with RYZUP Patient Support to provide education and understanding of this complex process. Candidates for this role will need to understand the Specialty Pharmacy process and work in conjunction with the RZYUP SP Liaison to understand how patient cases are working thru the SP system. This is necessary to provide updates not only to HCP offices, but internally at Avadel as well.

This is an exciting opportunity to be a part of a world class field reimbursement organization and make a meaningful impact for patients living with narcolepsy. The Field Reimbursement Manager will be a key contributor of the Patient Services and Market Access team working to provide insight from key customer interactions and an exceptional leader who will live and foster the Avadel values: Relentless, Confidence with Humility, Courageous, Insights to Impact and Togetherness

Essential Functions:

• Be a significant player in the development of Avadel’s Market Access Field Reimbursement Strategy across all assets and functions to ensure an integrated approach to broader HCP offices that delivers optimal access for patients to the portfolio, including ensuring an efficient cross-functional communication and feedback process.
• Provide critical engagement with HCP office staff educating them on RYZUP enrollment process and titration process so offices understand process when script is written
• It is vital that Field Reimbursement teams develop and maintain strong Relationship with each HCP office.
• Work together as one Avadel team in owning the relationship development of HCP offices with there respective Territory Business Manager
• Develop service materials to support educational efforts while in the field these are to include: Reimbursement, Prior Authorizations, Letters of Medical Necessity, Appeals, Welcome Kits, Compliance and Persistency, Data integration SP network, Pull thru strategies, Payer Policy, RYZUP process.
• Attend Quarterly Business Reviews.
• Implementation of Programs, Dinner, Lunch, etc. all educational in nature.
• Work Collaboratively across all internal Avadel teams with focus on Patient Support and Channel.
• Partner with Finance, Supply Chain, and Manufacturing teams in demand forecasting and pharmacy/wholesaler fulfillment throughout pre-launch and post-launch phases of product to ensure successful implementation of the trade/distribution strategy.
• Support and communicate Market Access strategies in partnership with the Payer Marketing team, Head of Contracting & Pricing Strategy, HEOR, Medical Affairs, and other cross-functional and senior corporate leadership, as appropriate
• Be the “Go To” brand leader in the field for HCP offices to call on when questions arise
• Educate HCP offices regarding REM’s protocol and certification process to ensure offices can prescribe product.
• Work collaboratively with all contracted partners
• Provide strong analytical work to improve process and performance, identify key metrics to track performance at a National and regional level

Experience and Qualifications:

• Bachelor’s degree required; advanced degree preferred
• 5+ years’ experience within the Pharma/biotech industry with that focused in either a sales or reimbursement related role
• Experience in the Rare Orphan Disease markets highly preferred
• Previous experience working in Field Reimbursement Ability to own build critical relationships with office staff
• Proven experience with success in pull thru strategies
• Experience in development of Field Access educational materials
• Previous launch experience directly with field access teams required
• Strong analytical expertise with ability to measure metrics and bring insights to data that will make a meaningful impact to patients
• Strong knowledge of Patient Services programs such as Copay, Quick Start/Bridge, LMN/Appeals
• For the health and safety of our employees, customers, and community, vaccination against COVID-19 is required as a condition of employment for this position and you must provide valid proof of vaccination

Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunities and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, marital status, ancestry, gender, gender identity, pregnancy, status as a covered veteran, or any other characteristic protected by federal, state, and/or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.